Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival

Abstract

Alloimmunization in SCD may be associated with chronic pain, risk of end-organ damage, and shorter survival. These novel findings suggest new directions for the investigation of immune response-mediated pathways common to alloimmunization and chronic pain.